Turkey

South Africa has recognised AI as a potential inventor. Selin Sinem Erciyas and Zeynep Çağla Üstün of Gün + Partners consider how other jurisdictions have approached patent applications for two inventions by the DABUS system

Aysel Korkmaz Yatkın, Selin Sinem Erciyas and Zeynep Çağla Üstün of Gün + Partners draw on Turkish case law to show the issue of patent trolls using loopholes to gain absolute rights can be overcome

Güldeniz Doğan Alkan and Ayşenur Çıtak Bozdağ of Gün + Partners explain the significance of a decision regarding a popular Star Trek hand gesture in response to an opposition filed by CBS

Selin Sinem Erciyas and Aysu Eryaşar of Gün + Partners explain why publication of a Turkish translation of an application is essential in ensuring protection for patent owners and claiming compensation for damages

Zeynep Seda Alhas, Pınar Arıkan and Baran Güney of Gün + Partners identify several shortcomings with the new provisions regarding domain name disputes in Turkey

The new system raises several questions for European Patent Convention countries that are not EU members, say Selin Sinem Erciyas, Aysel Korkmaz Yatkın, Zeynep Çağla Üstün and Aysu Eryaşar of Gün + Partners

Güldeniz Doğan Alkan and Cansu Evren of Gün + Partners say that a recent ruling raises the question of how many trademarks should be imitated for an act of bad faith to be recognised

Aysel Korkmaz Yatkin, Selin Sinem Erciyas, and Aysu Eryaşar of Gün + Partners report that the highly debated concept of plausibility is gaining prominence in Turkish invalidity proceedings

Zeynep Seda Alhas and Atahan Erkul of Gün + Partners explain a precedential ruling’s impact on brand owners seeking to obtain search and seizure warrants with regard to counterfeits

Selin Sinem Erciyas and Aysel Korkmaz Yatkın of Gün + Partners explain the significance of a ruling in Turkey on the validity of second medical use patents granted by the European Patent Office

Zeynep Seda Alhas and Dilan Sıla Kayalıca of Gün + Partners consider the Turkish IP office’s ruling on the opposition proceedings initiated by TBL Licensing, the owner of the Timberland trademark

Selin Sinem Erciyas of Gün + Partners suggests that intellectual property waivers and compulsory licensing are not the answer in developing and accessing vaccines, and explains why governments should be focused on R&D